127 related articles for article (PubMed ID: 24356412)
1. The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer.
Kolev V; Pereira EB; Schwartz M; Sarpel U; Roayaie S; Labow D; Momeni M; Chuang L; Dottino P; Rahaman J; Zakashansky K
Int J Gynecol Cancer; 2014 Jan; 24(1):70-4. PubMed ID: 24356412
[TBL] [Abstract][Full Text] [Related]
2. Hepatic resection for metachronous metastases from ovarian carcinoma.
Merideth MA; Cliby WA; Keeney GL; Lesnick TG; Nagorney DM; Podratz KC
Gynecol Oncol; 2003 Apr; 89(1):16-21. PubMed ID: 12694649
[TBL] [Abstract][Full Text] [Related]
3. Long-term Survivors After Liver Resection for Ovarian Cancer Liver Metastases.
Bacalbaşa N; Balescu I; Dima S; Popescu I
Anticancer Res; 2015 Dec; 35(12):6919-23. PubMed ID: 26637917
[TBL] [Abstract][Full Text] [Related]
4. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer.
Tay EH; Grant PT; Gebski V; Hacker NF
Obstet Gynecol; 2002 Jun; 99(6):1008-13. PubMed ID: 12052591
[TBL] [Abstract][Full Text] [Related]
5. Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
Felsinger M; Minar L; Weinberger V; Rovny I; Zlamal F; Bienertova-Vasku J
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():154-160. PubMed ID: 29957400
[TBL] [Abstract][Full Text] [Related]
6. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.
Bacalbasa N; Dima S; Brasoveanu V; David L; Balescu I; Purnichescu-Purtan R; Popescu I
World J Surg Oncol; 2015 Aug; 13():235. PubMed ID: 26243426
[TBL] [Abstract][Full Text] [Related]
7. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
8. Resection of recurrent ovarian or fallopian tube carcinoma involving the liver.
Yoon SS; Jarnagin WR; Fong Y; DeMatteo RP; Barakat RR; Blumgart LH; Chi DS
Gynecol Oncol; 2003 Nov; 91(2):383-8. PubMed ID: 14599870
[TBL] [Abstract][Full Text] [Related]
9. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR
Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412
[TBL] [Abstract][Full Text] [Related]
10. Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver.
Roh HJ; Kim DY; Joo WD; Yoo HJ; Kim JH; Kim YM; Kim YT; Nam JH
Arch Gynecol Obstet; 2011 Nov; 284(5):1223-9. PubMed ID: 21132314
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
[TBL] [Abstract][Full Text] [Related]
12. Salvage cytoreduction for chemorefractory ovarian cancer with peritoneal carcinomatosis: a last chance or futile efforts?
Chua TC; Robertson G; Liauw W; Morris DL
Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):478-84. PubMed ID: 21039384
[TBL] [Abstract][Full Text] [Related]
13. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
Salani R; Santillan A; Zahurak ML; Giuntoli RL; Gardner GJ; Armstrong DK; Bristow RE
Cancer; 2007 Feb; 109(4):685-91. PubMed ID: 17219441
[TBL] [Abstract][Full Text] [Related]
14. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
15. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
[TBL] [Abstract][Full Text] [Related]
16. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM
Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956
[TBL] [Abstract][Full Text] [Related]
17. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
[TBL] [Abstract][Full Text] [Related]
18. Determinants of survival after liver resection for metastatic colorectal carcinoma.
Parau A; Todor N; Vlad L
J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
[TBL] [Abstract][Full Text] [Related]
19. Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer.
Gasparri ML; Grandi G; Bolla D; Gloor B; Imboden S; Panici PB; Mueller MD; Papadia A
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1509-20. PubMed ID: 26660323
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
